4.7 Article

Altered JS-2 expression in colorectal cancers and its clinical pathological relevance

期刊

MOLECULAR ONCOLOGY
卷 5, 期 5, 页码 475-481

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.molonc.2011.06.003

关键词

Colorectum; Mucinous; Adenocarcinoma; Adenoma; JS-2 gene

类别

资金

  1. Griffith Health Institute

向作者/读者索取更多资源

JS-2 is a novel gene located at 5p15.2 and originally detected in primary oesophageal cancer. There is no study on the role of JS-2 in colorectal cancer. The aim of this study is to determine the gene copy number and expression of JS-2 in a large cohort of patients with colorectal tumours and correlate these to the clinicopathological features of the cancer patients. We evaluated the DNA copy number and mRNA expression of JS-2 in 176 colorectal tissues (116 adenocarcinomas, 30 adenomas and 30 non-neoplastic tissues) using real-time polymerase chain reaction. JS-2 expression was also evaluated in two colorectal cancer cell lines and a benign colorectal cell line. JS-2 amplification was noted in 35% of the colorectal adenocarcinomas. Significant differences in relative expression levels for JS-2 mRNA between different colorectal tissues were noted (p = 0.05). Distal colorectal adenocarcinoma had significantly higher copy number than proximal adenocarcinoma (p = 0.005). The relative expression level of JS-2 was different between colonic and rectal adenocarcinoma (p = 0.007). Mucinous adenocarcinoma showed higher JS-2 expression than non-mucinous adenocarcinoma (p = 0.02). Early T-stage cancers appear to have higher JS-2 copy number and lower expression of JS-2 mRNA than later stage cancers (p = 0.001 and 0.03 respectively). Colorectal cancer cell lines showed lower expression of JS-2 than the benign colorectal cell line. JS-2 copy number change and expression were shown for the first time to be altered in the carcinogenesis of colorectal cancer. In addition, genetic alteration of JS-2 was found to be related to location, pathological subtypes and staging of colorectal cancer. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Implications of estrogen and its receptors in colorectal carcinoma

Plabon Kumar Das, Joti Saha, Suja Pillai, Alfred K-Y Lam, Vinod Gopalan, Farhadul Islam

Summary: This study highlights the significant role of estrogens and their receptors, particularly ERβ, in the pathogenesis of colorectal carcinoma (CRC). Understanding the underlying mechanisms of estrogen and its receptors in CRC pathogenesis could offer new insights for therapeutic development.

CANCER MEDICINE (2023)

Article Medicine, General & Internal

Clinical and economic burden of benign and malignant skin lesions in renal transplant recipients

Zaw Thet, Alfred K. Lam, Tony Pham, Shu-Kay Ng, Jason C. Steel, Sirena Sawhney, Carolina T. Arellano, Soe Yu Aung, Thin Han, Dwarakanathan Ranganathan, George John, Christina Pepito, Tamlyn Rautenberg, Tien K. Khoo

Summary: This study evaluated the clinical and economic burden of benign and malignant skin lesions in renal transplant recipients in Australia using Medicare data. The results showed that 40% of patients were diagnosed with benign skin lesions, 38% with nonmelanoma skin carcinoma (NMSC), and 2% with melanoma during a 2-year follow-up. The total direct costs to Medicare were $48,806 Australian Dollars, indicating a significant burden in the renal transplantation setting.

INTERNAL MEDICINE JOURNAL (2023)

Review Otorhinolaryngology

Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review

Sharmin Aktar, Hooman Baghaie, Farhadul Islam, Vinod Gopalan, Alfred King-Yin Lam

Summary: This review examines the current status of circulating tumor cells (CTCs) in patients with head and neck squamous cell carcinomas (HNSCC), highlighting their diagnostic and prognostic value. Various analysis approaches, such as single-CTC analysis and identifying phenotypic surface markers, have shown promise in predicting disease progression and treatment efficacy. However, limitations in CTC detection and characterization methods remain.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2023)

Review Medicine, General & Internal

Reducing inappropriate polypharmacy for older patients at specialist outpatient clinics: a systematic review

Louise Clarkson, Laura Hart, Alfred K. K. Lam, Tien K. K. Khoo

Summary: This review examined the effectiveness of deprescribing interventions within specialist outpatient clinics for patients aged 60 and older. Nineteen studies showed that implementing deprescribing interventions in certain clinic settings can significantly reduce medication load, but with limited study quality and the need for further research.

CURRENT MEDICAL RESEARCH AND OPINION (2023)

Article Biochemistry & Molecular Biology

Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma

Sharmin Aktar, Faysal Bin Hamid, Sujani Madhurika Kodagoda Gamage, Tracie Cheng, Nahal Parkneshan, Cu Tai Lu, Farhadul Islam, Vinod Gopalan, Alfred King-yin Lam

Summary: Information on genetic alterations of driver cancer genes in circulating tumor cells (CTCs) and their immune microenvironment can be used as a real-time monitoring platform for translational applications. This study investigated gene expression profiling in CTCs and peripheral blood mononuclear cells (PBMCs) of colorectal carcinoma (CRC) patients. The presence of higher numbers of CTCs was correlated with advanced cancer stages and adenocarcinoma subtypes. Patients with lower numbers of CTCs had higher expression of KRAS, which was negatively correlated with tumor perforation and distant metastasis. CTLA-4 was highly expressed in both CTCs and PBMCs and positively correlated with KRAS in CTCs. Dysregulation of KRAS in CTCs may alter the expression of CTLA-4, providing insights into therapeutic target selection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities

Ghazaleh Pourali, Nima Zafari, Hamid Fiuji, Jyotsna Batra, Elham Nazari, Majid Khazaei, Seyed Mahdi Hassanian, Mahrou Vahabi, MohammadAli Kiani, Majid Ghayour-Mobarhan, Godefridus J. Peters, Gordon A. Ferns, Alfred King-yin Lam, Elisa Giovannetti, Amir Avan

Summary: There is a complex interaction between pro-tumoural and anti-tumoural networks in the tumour microenvironment (TME). Understanding these interactions within the TME is crucial for the development of innovative cancer treatments. Extracellular vesicles (EVs) serve as carriers of various materials and play a vital role in the communication between tumour cells and non-tumour cells. This review summarizes recent findings regarding the involvement of EVs in the metabolic reprogramming of gastrointestinal cancers and highlights potential therapeutic approaches.

CYTOKINE & GROWTH FACTOR REVIEWS (2023)

Correction Biochemistry & Molecular Biology

Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma (vol 24, 5051, 2023)

Sharmin Aktar, Faysal Bin Hamid, Sujani Madhurika Kodagoda Gamage, Tracie Cheng, Nahal Pakneshan, Cu Tai Lu, Farhadul Islam, Vinod Gopalan, Alfred King-yin Lam

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer

Fatemeh Khojasteh-Leylakoohi, Reza Mohit, Nima Khalili-Tanha, Alireza Asadnia, Hamid Naderi, Ghazaleh Pourali, Zahra Yousefli, Ghazaleh Khalili-Tanha, Majid Khazaei, Mina Maftooh, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Soodabeh Shahidsales, Alfred King-yin Lam, Elisa Giovannetti, Elham Nazari, Jyotsna Batra, Amir Avan

Summary: This study utilized bioinformatics and machine learning methods to identify and validate differentially expressed genes and microRNAs associated with pancreatic ductal adenocarcinoma (PDAC). The results demonstrated the prognostic and diagnostic value of these genes and microRNAs in PDAC.

SCIENTIFIC REPORTS (2023)

Article Genetics & Heredity

Correlation between KRAS Mutation and CTLA-4 mRNA Expression in Circulating Tumour Cells: Clinical Implications in Colorectal Cancer

Sharmin Aktar, Farhadul Islam, Tracie Cheng, Sujani Madhurika Kodagoda Gamage, Indra Neil Choudhury, Md Sajedul Islam, Cu Tai Lu, Faysal Bin Hamid, Hirotaka Ishida, Ichiro Abe, Nan Xie, Vinod Gopalan, Alfred K. Lam

Summary: This study investigated the genomic variations of KRAS in circulating tumour cells (CTCs) and matched colorectal carcinoma (CRC) tissues. The results showed differences in KRAS mutations between CTCs and CRC tissues. Patients with KRAS mutations in CTCs were more likely to have poorly differentiated tumors and lymph node metastasis. These findings suggest the genetic basis of KRAS as a potential target for immunotherapy.
Article Oncology

Therapeutic Potential of Targeting the Cytochrome P450 Enzymes Using Lopinavir/Ritonavir in Colorectal Cancer: A Study in Monolayers, Spheroids and In Vivo Models

Maryam Alaei, Seyedeh Elnaz Nazari, Ghazaleh Pourali, AliReza Asadnia, Mehrdad Moetamani-Ahmadi, Hamid Fiuji, Hamid Tanzadehpanah, Fereshteh Asgharzadeh, Fatemeh Babaei, Fatemeh Khojasteh-Leylakoohi, Ibrahim Saeed Gataa, Mohammad Ali Kiani, Gordon A. Ferns, Alfred King-yin Lam, Seyed Mahdi Hassanian, Majid Khazaei, Elisa Giovannetti, Amir Avan

Summary: In this study, the potential of targeting the enzyme cytochrome P450 (CYP450) using lopinavir/ritonavir in colorectal cancer (CRC) was explored. Experimental methods were employed to assess the effects of lopinavir/ritonavir on CRC, and it was found that inhibiting CYP450 reduced cell proliferation, induced cell death, and suppressed cell migration. Lopinavir/ritonavir also inhibited tumor growth and fibrosis. These findings suggest that targeting CYP450 with lopinavir/ritonavir has therapeutic potential in CRC and further research in this area is needed.

CANCERS (2023)

Article Oncology

The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach

Alireza Asadnia, Elham Nazari, Ladan Goshayeshi, Nima Zafari, Mehrdad Moetamani-Ahmadi, Lena Goshayeshi, Haneih Azari, Ghazaleh Pourali, Ghazaleh Khalili-Tanha, Mohammad Reza Abbaszadegan, Fatemeh Khojasteh-Leylakoohi, Mohammadjavad Bazyari, Mir Salar Kahaei, Elnaz Ghorbani, Majid Khazaei, Seyed Mahdi Hassanian, Ibrahim Saeed Gataa, Mohammad Ali Kiani, Godefridus J. Peters, Gordon A. Ferns, Jyotsna Batra, Alfred King-yin Lam, Elisa Giovannetti, Amir Avan

Summary: This study identified genetic variants and differentially expressed genes in colorectal cancer patients using genome-wide DNA and RNA sequencing. ASPHD1 and ZBTB12 genes were identified as potential prognostic markers, and two novel genetic variants were found to potentially regulate gene expression. These findings provide a proof of concept for the evaluation of emerging biomarkers in colorectal cancer.

CANCERS (2023)

Meeting Abstract Transplantation

CHARACTERISTICS AND OUTCOMES OF MPO VERSUS PR3 ANCA ASSOCIATED GLOMERULONEPHRITIS: A REPORT FROM AN AUSTRALIAN POPULATION-BASED STUDY

Ken Chau, Shu Kay Ng, Alfred Lam, Tien Khoo, Dwarakanathan Ranganathan

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Meeting Abstract Transplantation

INPATIENT POLYPHARMACY AND THE AGING KIDNEY

Louise Clarkson, Tien Khoo, Alfred Lam, Anthony Griffiths

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Meeting Abstract Transplantation

EPIDEMIOLOGY OF GLOMERULAR DISEASES IN THE PRE- AND POST-COVID-19 ERA IN CENTRAL QUEENSLAND, AUSTRALIA

Zaw Thet, Thin Han, Leo Francis, Nyi Aung, Ken Chau, Shu Kay Ng, Mar Myint, Jennifer Borg, Alfred Lam, Tien Khoo, Dwarakanathan Ranganathan

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Cell Biology

A diagnostic pitfall; small cell carcinoma-like features in basaloid squamous cell carcinoma of the esophagus

Hirotaka Ishida, Atsuko Kasajima, Takuro Yamauchi, Ryujiro Akaishi, Shunsuke Ueki, Yusuke Taniyama, Fumiyoshi Fujishima, Tomoyuki Koike, Takashi Kamei, Alfred King-yin Lam, Hironobu Sasano

Summary: Esophageal basaloid squamous cell carcinoma can resemble small cell carcinoma biopsy specimens and cause difficulties in pathology diagnosis. Small cell carcinoma-like features are frequent in biopsies but do not impact patients' outcome. Immunohistochemically, synapto-physin and chromogranin A are consistently negative, while CD56 is expressed in some cases. p16 expression may also be detected in basaloid squamous cell carcinoma.

HISTOLOGY AND HISTOPATHOLOGY (2023)

Article Oncology

PPM1D activity promotes the replication stress caused by cyclin E1 overexpression

Andra S. Martinikova, Miroslav Stoyanov, Anna Oravetzova, Yannick P. Kok, Shibo Yu, Jana Dobrovolna, Pavel Janscak, Marcel van Vugt, Libor Macurek

Summary: Oncogene-induced replication stress is a major cause of genome instability in cancer cells. This study reveals that increased activity of PPM1D exacerbates replication stress caused by cyclin E1 overexpression, leading to abnormal cell cycle progression and accumulation of DNA copy number alterations. Pharmacological inhibition of PPM1D can alleviate replication stress-induced genome instability.

MOLECULAR ONCOLOGY (2024)

Article Oncology

ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway

Alamelu G. Bharadwaj, Meghan E. McLean, Margaret L. Dahn, Hannah F. Cahill, Marie-Claire D. Wasson, Raj Pranap Arun, Olivia L. Walker, Brianne M. Cruickshank, Wasundara Fernando, Jaganathan Venkatesh, Penelope J. Barnes, Gillian Bethune, Gregory Knapp, Lucy K. Helyer, Carman A. Giacomantonio, David M. Waisman, Paola Marcato

Summary: ALDH1A3 regulates the plasminogen activation pathway to promote breast cancer metastasis. Co-expression of ALDH1A3 and tPA is associated with TNBC subtype, high tumor grade, and recurrent metastatic disease.

MOLECULAR ONCOLOGY (2024)

Article Oncology

Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression

Nayela N. Chowdhury, Yi Yang, Ananya Dutta, Michelle Luo, Zimu Wei, Sara R. Abrahams, Alexey S. Revenko, Fenil Shah, Lindsey A. Miles, Robert J. Parmer, Bas de Laat, Alisa S. Wolberg, James P. Luyendyk, Melissa L. Fishel, Matthew J. Flick

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal metastatic disease associated with robust activation of the coagulation and fibrinolytic systems. Primary fibrinolytic protease plasminogen promotes PDAC tumor growth and metastatic potential through engaging plasminogen receptors on tumor cells.

MOLECULAR ONCOLOGY (2024)

Article Oncology

Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread

Nuria Gendrau-Sanclemente, Agnes Figueras, Kristina Gracova, Alvaro Lahiguera, Elisenda Alsina-Sanchis, Juan A. Marin-Jimenez, August Vidal, Xavier Matias-Guiu, Sergi Fernandez-Gonzalez, Marc Barahona, Lola Marti, Jordi Ponce, Francesc Vinals

Summary: High-grade serous ovarian cancer (HGSOC), the deadliest gynecological malignancy, spreads through transcoelomic dissemination. This study reveals that platelet-derived growth factor receptor beta (PDGFRβ) is essential for the formation of tumorspheres in HGSOC. Inhibition of PDGFRβ blocks the clustering of ovarian cancer cells and prevents peritoneal dissemination.

MOLECULAR ONCOLOGY (2024)